In this Part IV, we'll cover the wet age-related macular degeneration (“AMD”) franchise with RGX-314. RGX-314 delivered the robust Phase 1 clinical …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *